Nanopharm was founded to address industry-wide challenges in converting drugs from concept into viable, effective and consistent nasal and orally inhaled drug products.
The company has established itself as a leading provider of tailored analytical and formulation support during all phases of drug development of orally inhaled drug products. Our unique processing technology and formulation development tools aid identification of critical material attributes, their relationship with critical processing parameters and drug product functionality.